Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03238495
Title Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer (HERMET)
Acronym HERMET
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Qamar Khan
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.